Inactive Instrument
Lipidor AB (publ) Stock OTC Markets
Stocks
LIPD.F
SE0012558617
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 92.63K | |
| +0.13% | +1.56% | +47.35% | +164.01% | 1,067B | |
| +0.97% | +5.10% | +58.02% | +53.98% | 635B | |
| -0.94% | +0.95% | +35.02% | +81.05% | 458B | |
| +1.41% | +7.75% | +38.93% | +32.88% | 347B | |
| +1.28% | +2.82% | +38.42% | +43.21% | 295B | |
| +1.72% | +2.33% | +19.31% | +20.79% | 262B | |
| +1.84% | -1.03% | -27.78% | -38.45% | 216B | |
| +0.06% | +2.72% | +22.73% | +59.97% | 203B | |
| +0.94% | -2.80% | +12.32% | +69.09% | 161B | |
| Average | +0.72% | +1.33% | +27.15% | +54.06% | 404.83B | |
| Weighted average by Cap. | +0.54% | +1.95% | +36.75% | +79.84% |
Employees
4
Sector
Pharmaceuticals
